Helene Kolding

Title: Helene Kolding: Innovator in Enantioselective Chemistry

Introduction

Helene Kolding is a prominent inventor based in Lyngby, Denmark. She has made significant contributions to the field of chemistry, particularly in the area of enantioselective methods. Her work has implications for various applications in pharmaceuticals and materials science.

Latest Patents

Helene Kolding holds a patent for "Liphagal enantiomers and their derivatives and precursors, and enantioselective methods of making the same." This patent describes enantioenriched compositions of liphagal and its derivatives, which include more than 50 mol % of a first enantiomer based on the total amount of a first and a second enantiomer. The method of making these compositions involves catalytic enantioselective alkylation, ring expansion, and intramolecular aryne cyclization. She has 1 patent to her name.

Career Highlights

Helene Kolding is affiliated with the California Institute of Technology, where she continues her research and development in chemistry. Her innovative approaches have garnered attention in the scientific community, contributing to advancements in enantioselective synthesis.

Collaborations

Throughout her career, Helene has collaborated with notable colleagues, including Ryan McFadden and Scott C. Virgil. These partnerships have enhanced her research and expanded the impact of her work in the field.

Conclusion

Helene Kolding is a trailblazer in enantioselective chemistry, with a focus on innovative methods and compositions. Her contributions are paving the way for future advancements in the field.